Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab

Wungki Park, Deukwoo Kwon, Diana Saravia, Amrita Desai, Fernando Vargas, Mohamed El Dinali, Jessica Warsch, Roy Elias, Young Kwang Chae, Dae Won Kim, Sean Warsch, Adrian Ishkanian, Chukwuemeka Ikpeazu, Raja Mudad, Gilberto Lopes, Mohammad Jahanzeb

Research output: Contribution to journalArticle

11 Scopus citations
Original languageEnglish (US)
JournalClinical Lung Cancer
DOIs
StateAccepted/In press - Jan 1 2018

    Fingerprint

Keywords

  • Advanced non-small cell lung cancer
  • Algorithm
  • Biomarker model
  • Clinical outcome
  • Immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Park, W., Kwon, D., Saravia, D., Desai, A., Vargas, F., El Dinali, M., Warsch, J., Elias, R., Chae, Y. K., Kim, D. W., Warsch, S., Ishkanian, A., Ikpeazu, C., Mudad, R., Lopes, G., & Jahanzeb, M. (Accepted/In press). Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2017.12.007